Skip to Main Content

Paper Details

Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using alpha-difluoromethylornithine.
Cytometry
15
1999
CIN, CIN III, DFMO, alpha-difluoromethylornithine, cells, cervical cancer, cervical carcinoma, cervical intraepithelial neoplasia, patients

Datasets